MC1R is dispensable for the proteinuria reducing and glomerular protective effect of melanocortin therapy

Melanocortin therapy by using adrenocorticotropic hormone (ACTH) or non-steroidogenic melanocortin peptides attenuates proteinuria and glomerular injury in experimental glomerular diseases and induces remission of nephrotic syndrome in patients with diverse glomerulopathies, even those resistant to...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Qiao, Yingjin, Berg, Anna-Lena, Wang, Pei, Ge, Yan, Quan, Songxia, Zhou, Sijie, Wang, Hai, Liu, Zhangsuo, Gong, Rujun
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4897792/
https://ncbi.nlm.nih.gov/pubmed/27270328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep27589
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars